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ABSTRACT: Breast cancers are potentially life-threatening 
malignancies in women. Development of cancer produces oxidative 
stress, which increases with disease progression. Hence, studies on 
antioxidants may be the most promising area of research for this 
clinical menace. We analysed serum superoxide dismutase (SOD), 
catalase (CAT) in women with breast cancer. The changes in the 
levels of serum superoxide dismutase and catalase are measured in 
breast cancer patients to assess the oxidative stress. A significant 
increase in the level of superoxide dismutase and a lower catalase 
activity was observed in all the three categories of breast cancer 
patients compared to normal individuals. The results suggested that 
high ROS production supports the oxidative stress in breast cancer. 
So, the treatment with antioxidants in the initial stages of the 
disease may be useful as secondary therapy. 
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Introduction 
Breast cancer is one of the most common cancers in women of the 
developed and developing countries. Experimental investigations as 
well as clinical and epidemiological studies implicate the involvement 
of oxygen derived radicals such as singlet oxygen (1O2), superoxide 
anions (O2•¯), hydrogen peroxide (H2O2) and hydroxyl radical (OH•) 
in the etiology of cancer (Oberley LW, Oberley TD 1986, Fisher SM 
et.al., 1983). Free radicals are formed in both physiological and 
pathological conditions in mammalian tissues. In healthy conditions 
at cellular level, a subtle balance exists between the free radical 
generation and the antioxidant defense.  Reactive Oxygen species 
(ROS) are essential for multiple normal physiological processes like 
cell differentiation (Abe JI et al., 2000), apoptosis (Ghosh, 1998), 
cell immunity (Golub et al., 1985) and cellular defense against 
microorganisms (Lajarin et al., 1999) at low concentrations. Excess 
generation of these oxygen free radicals and oxidants generate a 
phenomenon called oxidative stress which cause oxidative damage 
to biomolecules resulting in lipid peroxidation, mutagenesis and 
carcinogenesis. There is accumulating evidence from animal and 
human systems implicating a role of oxidative stress and lipid 
peroxidation in the development of breast cancer (Mianying Wang et 
al., 1996). Several studies reported that malondialdehyde; the end 
product of lipid peroxidation can cause cross-linking in lipids, 
proteins and nucleic acids (Freeman BA 1982). It is also evident that 
overproduction of ROS/RNS (Halliwell B, 1989, Kang, 2002) plays an 
important role in the promotion and progression of human cancers, 
including breast cancer (Aghvami T et al., 2006, Ray G et al., 2000, 
Huang YL et al., 1996, Yeh, 2005). The human body is equipped 
with certain enzymatic and non enzymatic antioxidant systems 
(Faruk Tas et al., 2005, Portakal O et al., 2000). Antioxidants are 
known to dispose, scavenge, and suppress the formation of free 
radicals or oppose their action and increase with the severity of the 
disease (Singh R et al., 2003, Galleotti T et al., 1991).  
The precise mechanism of the oxidative stress being induced in 
breast cancer is still not exactly understood and documented. 
Hence, in the present study an attempt has been made to determine 
the alteration in oxidant-antioxidant status in breast cancer patients, 
by estimating the antioxidants superoxide dismutase (SOD) and 
catalase (CAT). 
 
Materials and Methods  
This study was conducted at Mahatma Gandhi Cancer and Research 
Institute and in the Department of Biochemistry, Andhra University, 
Visakhapatnam. 116 clinically and histopathologically proven breast 
cancer patients were chosen for the study. Due permission was 
obtained from the management of the Mahatma Gandhi Cancer and 
Research Institute before the commencement of the work. The 
written consent of the patients was also taken. An equal number of 
age matched healthy subjects were considered as normal/control. 
The complete clinical and personal history of the patients was 
recorded. The subjects were ranging from 30-69 years of age. 
Patients suffering from diseases of any origin other than breast 
cancer were excluded from the study.  
The study subjects are segregated into four groups so that the age 
group between 30-39 is referred to as group-1, followed by group-2 
from40-49 years of age, then group-3 from 50-59 years and finally 
group-4 from the age of 60 to 69 years. The study was carried out 
in three different categories of breast cancer patients in different 
clinical conditions.   
Category I: The selected study parameters like superoxide 
dismutase and catalase levels were analyzed in untreated breast 
cancer patients undergoing treatment for the first time.  
Each study group (age) was classified into four stages i.e., stage-I, 
II, III and IV according to Manchester’s classification based on a 
clinical evaluation of the patients case study. 
Category II: The study parameters were also monitored 
continuously in breast cancer patients for more than 2 years at time 
intervals of 3, 6, 12, 18 and 24 months, irrespective of type of 
clinical treatment / age/ stage of breast cancer. 
Category III: The study parameters were also investigated 
irrespective of the patient’s age and stage of the cancer in 10 
patients each, who are undergoing different types of clinical 
treatments like chemotherapy, surgical removal of breast tissue and 
radiation. 
Blood was collected by venous arm puncture in patients and 
controls. The blood collected was centrifuged to separate the serum, 
with which the clinical investigations for the levels of selected 
antioxidants were carried out. SOD activity was determined by the 
method of Beauchamp and Fedovich, 1976 based on the enzyme 
inhibition required for inhibiting the reduction of NBT by 50%. 
Catalase activity was measured by the titrimetric method described 
by Radhakrishnan and Sarma, 1963. Protein was estimated by the 
method of Lowry et al. (1951). All the chemicals used were of 
analytical grade.  
Statistical analysis between the normal individuals and patients was 
performed by the student t-test. The data expressed as Mean ± SD 
and p<0.05 was considered as significant. 
 
Results and Discussion 
The Mean values of SOD and CAT for category I patients are 
indicated in the fig 1, the mean and independent values for the 
category II patients are indicated in tables 1 and the mean values 
for category III patients are shown in fig 2 respectively. 
In the present study, we assessed the levels of serum SOD and CAT 
in patients with breast cancer. In category I patients a significant 
increase in the serum SOD levels were observed compared to the 
control. A steady increase in the activity of SOD was observed in the 
stage-I to stage-IV as reported in the fig 1. The rise in serum SOD 
activity in the group 2 & 3 of stages III and IV correlates with the 
progression of malignancy and the release of serum SOD from 
rapidly multiplying tumor cells may be an effort to protect 
themselves from the oxidative damage (Seth RK, et al, 2003). 
Superoxide anions are highly reactive and accumulation of these has 
also been reported in tumor cells (Devi GS et al, 2000). The over 
expression or the high levels of the SOD might be an adaptive 
response and it results in increased dismutation of the superoxide 
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anions to hydrogen peroxide. The SOD activity was observed to 
have proportionally increased up till group-II with the age and 
decline in the later age groups. Saxena et al, (2006) reported that 
SOD activity was significantly low in the elderly people as compared 
to younger people which directs towards reduction in its protective 
and superoxide radical scavenging action in elderly people. The 
diminished activity of SOD could be explained on the basis of its 
progressive enzyme inactivation by resultant product of dismutation 
reaction i.e., H2O2 or due to increase in the glycosylation of SOD 
with aging. In category II patients the serum SOD activity was 
observed to be consistent with the above observations (table 1). 
These results show a correlation between redox status and tumour 
progression suggesting that up regulation of antioxidants enables 
tumour cells to counter oxidative stress as reported earlier 
(Kumaraguruparan R et.,al, 2002). Serum SOD levels in category III 
patients was observed to be higher compared to the normal (fig 2). 
A similar observation was reported by Carmia Borek (2004), who 
showed that oxidative stress increases with disease progression and 
the levels of antioxidants are further decreased in response to the 
treatment.
  
Fig 1. Levels of various serum antioxidants in untreated breast cancer patients undergoing treatment for the first time 
 
 
 
 
 
 
 
 
 
 
 
Group 1: 30-39, Group-2: 40-49, Group- 3: 50-59, Group 4: 60-69.  
All the values are expressed as Mean.* p<0.05 compared to controls 
 
 
Table 1: Serum antioxidant levels in continuously monitored Breast cancer patients compared to normal 
 
Name of 
the 
Antioxidant 
Normal 3 Months 6Months 12Months 18Months 24Months 
SOD 17.55 23.25 26.95 33.8 41.13 43.8 
CAT 54.2 47.8 47.7 46.8 46.03 45.15 
SOD- Superoxide dismutase, CAT-Catalase 
†All the values are expressed as Mean of 6 subjects 
 
Fig 2: Serum antioxidant levels in Category III breast cancer patients under different clinical treatments like surgery, chemotherapy and radiation compared to normal 
 
 
 
 
 
         
 
 
 
‡All the values are expressed as Mean of 10 subjects 
 
CAT activity has been observed to be relatively insignificant in 
category I patients as the disease progression compared to the 
control. Similar studies were also reported by Kumarguruparan et 
al., (2002).  However, the catalase activity in stages I, II and III 
were found to be reasonably low. (fig 1). The decreased activity of 
CAT may be a compensatory regulation in response to increased 
oxidative stress. It has also been reported that the low levels of CAT 
are due to the inactivation of the enzyme by the superoxide anions 
(Keno Y, 1975).  Recently Tas et al, 2005 reported a decreased CAT 
activity in all stages of breast cancer and showed that lipid 
peroxidation in breast cancer tissue was enhanced compared to 
non-malignant tissue. Further they reported that higher oxygen free 
radical production and decreased catalase activity supporting the 
oxidative stress hypothesis in breast carcinogenesis. CAT activity in 
category II and category III patients was observed to be lower than 
the normal healthy women. (table 1 and fig 2). Our results are also 
similar to the findings of Punnonen et al, 1994 and these low levels 
might be due to treatment by anticancer drugs which reduces 
antioxidants and induces oxidative stress which increases with 
disease progression (Carmia Borek, 2004).  
From the above observations of our study, it is detected that there is 
an increase in the serum SOD activity which show a higher free 
radical production and a decrease in the CAT levels are seen. The 
decreased levels of CAT results in accumulation of large amounts of 
hydrogen peroxide resulting in higher production of OH• radicals 
resulting in oxidative stress in breast cancer. The increased activities 
of antioxidants enzymes may be a compensatory regulation in 
response to this increased oxidative stress. Therefore, exogenous 
administration of antioxidants may be helpful in the management of 
breast cancer. So, the treatment with antioxidants in the initial 
stages of the disease may be useful as secondary therapy to prevent 
the oxidative damage.  
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